Search by Drug Name or NDC

    NDC 00019-1323-00 Optiray 678 mg/mL Details

    Optiray 678 mg/mL

    Optiray is a INTRA-ARTERIAL; INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Liebel-Flarsheim Company LLC. The primary component is IOVERSOL.

    Product Information

    NDC 00019-1323
    Product ID 0019-1323_abc7573e-aa40-4f9a-8025-0f7f488bf0c7
    Associated GPIs 94402055002068
    GCN Sequence Number 016226
    GCN Sequence Number Description ioversol SYRINGE 320 MG/ML INTRAVEN
    HIC3 A6U
    HIC3 Description CARDIOVASCULAR DIAGNOSTICS-RADIOPAQUE
    GCN 21581
    HICL Sequence Number 004703
    HICL Sequence Number Description IOVERSOL
    Brand/Generic Brand
    Proprietary Name Optiray
    Proprietary Name Suffix 320
    Non-Proprietary Name Ioversol
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route INTRA-ARTERIAL; INTRAVENOUS
    Active Ingredient Strength 678
    Active Ingredient Units mg/mL
    Substance Name IOVERSOL
    Labeler Name Liebel-Flarsheim Company LLC
    Pharmaceutical Class Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA020923
    Listing Certified Through 2024-12-31

    Package

    NDC 00019-1323-00 (00019132300)

    NDC Package Code 0019-1323-00
    Billing NDC 00019132300
    Package 20 SYRINGE, PLASTIC in 1 CARTON (0019-1323-00) / 100 mL in 1 SYRINGE, PLASTIC
    Marketing Start Date 2012-03-04
    NDC Exclude Flag N
    Pricing Information N/A